Lineage Cell Therapeutics Company

Develop and manufacture specialized, terminally-differentiated human cells from our pluripotent and progenitor cell starting materials.
Technology: Regenerative Medicine
Industry: BioEngineering
Headquarters: Carlsbad, California, United States
Founded Date: 1990
Employees Number: 101-250
Funding Status: IPO
Investors Number: 1
Total Funding: 108808804
Estimated Revenue: Less than $1M
Last Funding Date: 2021-03-08
Last Funding Type: Post-IPO Equity

Visit Website
Register and Claim Ownership